Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: May 26, 2025
Date Accepted: Dec 5, 2025

The final, peer-reviewed published version of this preprint can be found here:

Identifying Patient Sentiment in Atopic Dermatitis Treatment: Large Language Model Approach

Cummins JA, Yu J

Identifying Patient Sentiment in Atopic Dermatitis Treatment: Large Language Model Approach

JMIR Form Res 2026;10:e78054

DOI: 10.2196/78054

PMID: 41482273

PMCID: 12811741

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Identifying Patient Sentiments for Atopic Dermatitis Treatment: A Large Language Model Approach

  • Jack Alexander Cummins; 
  • JiaDe Yu

ABSTRACT

A novel methodology applying GPT-4o to analyze sentiment in over 27,000 Reddit comments demonstrated superior accuracy compared to traditional NLP approaches when evaluating patient experiences with atopic dermatitis medications.


 Citation

Please cite as:

Cummins JA, Yu J

Identifying Patient Sentiment in Atopic Dermatitis Treatment: Large Language Model Approach

JMIR Form Res 2026;10:e78054

DOI: 10.2196/78054

PMID: 41482273

PMCID: 12811741

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.